Released May 20, 2013, during market hours
10-Q filed May 20, 2013, 50 days after period end · 0001213900-13-002776
Q1 2013 · 10-Q
Revenue$4.66M$4.66M +2.6% vs Q1 2012−30.3% vs Q4 2012
Net Income-$676.33K-$676.33K N/M vs Q1 2012N/M vs Q4 2012
EPS Diluted-$0.05-$0.05 N/M vs Q1 2012no prior Q4 2012 on file
Gross Profit$1,665,626+4.9%
Operating Income-$39,893N/M
Operating Cash Flow-$101,190N/M
Free Cash Flowderived-$847,223N/M
Margins · derived
Gross margin35.7%+0.8 pt vs Q1 2012
Operating margin-0.9%−11.6 pt vs Q1 2012
Net margin-14.5%+0.3 pt vs Q1 2012
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $4.66M | $4.54M | $5.94M |
| Net Income | -$676.33K | -$670.98K | -$2.02M |
| EPS Diluted | -$0.05 | -$0.05 | -$0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tanke Biosciences Corp · CIK 1452011 · Engraved from SEC EDGAR